Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Node

Showing results (431-440 of 717) with videos related to

Pageof 72
Sort By:
Heliyon|May 30, 2023
Cardiovascular events after the initiation of immune checkpoint inhibitorsYuta Suzuki, Hidehiro Kaneko, Yuichi Tamura, et al.
Journal of Atherosclerosis and Thrombosis|December 21, 2020
Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin TherapyMasato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 10, 2002
Adenosine-induced cardiac gene expression of ischemic murine hearts revealed by cDNA array hybridizationMasanori Asakura, Masafumi Kitakaze, Yasuhiko Sakata, et al.
European Heart Journal Open|March 6, 2026
Association between depression and risk of ischaemic stroke in patients with atrial fibrillationKeitaro Senoo, Hidehiro Kaneko, Yuta Suzuki, et al.
Oncology|March 20, 2023
Sex-Specific Differences in the Risk of Heart Failure following Anti-HER2 Monoclonal Antibody TherapyYuta Suzuki, Hidehiro Kaneko, Yuicui Tamura, et al.
Journal of Cardiology|June 15, 2025
Association of lean mass index with a risk of incident stroke: a nationwide epidemiological cohort studyTakuma Ishibashi, Hidehiro Kaneko, Yuta Suzuki, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 7, 2024
Practical use and target value of urine sodium-to-potassium ratio in assessment of hypertension risk for Japanese: Consensus Statement by the Japanese Society of Hypertension Working Group on Urine Sodium-to-Potassium RatioTakashi Hisamatsu, Mana Kogure, Yasuharu Tabara, et al.
American Journal of Hypertension|April 11, 2025
A Randomized Clinical Trial of ICT-based Interventions for Sodium and Potassium Regulation in Healthy AdultsYuichiro Yano, Kaori Kitaoka, Takayoshi Ohkubo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 3, 2024
Effects of renal denervation on blood pressure in patients with hypertension: a latest systematic review and meta-analysis of randomized sham-controlled trialsYukako Ogoyama, Makiko Abe, Keisuke Okamura, et al.
Cardiovascular Diabetology|June 17, 2020
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapyMasato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Pageof 72

Showing results (431-440 of 717) with videos related to

Sort By:
Pageof 72
Heliyon|May 30, 2023
Cardiovascular events after the initiation of immune checkpoint inhibitorsYuta Suzuki, Hidehiro Kaneko, Yuichi Tamura, et al.
Journal of Atherosclerosis and Thrombosis|December 21, 2020
Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin TherapyMasato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 10, 2002
Adenosine-induced cardiac gene expression of ischemic murine hearts revealed by cDNA array hybridizationMasanori Asakura, Masafumi Kitakaze, Yasuhiko Sakata, et al.
European Heart Journal Open|March 6, 2026
Association between depression and risk of ischaemic stroke in patients with atrial fibrillationKeitaro Senoo, Hidehiro Kaneko, Yuta Suzuki, et al.
Oncology|March 20, 2023
Sex-Specific Differences in the Risk of Heart Failure following Anti-HER2 Monoclonal Antibody TherapyYuta Suzuki, Hidehiro Kaneko, Yuicui Tamura, et al.
Journal of Cardiology|June 15, 2025
Association of lean mass index with a risk of incident stroke: a nationwide epidemiological cohort studyTakuma Ishibashi, Hidehiro Kaneko, Yuta Suzuki, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 7, 2024
Practical use and target value of urine sodium-to-potassium ratio in assessment of hypertension risk for Japanese: Consensus Statement by the Japanese Society of Hypertension Working Group on Urine Sodium-to-Potassium RatioTakashi Hisamatsu, Mana Kogure, Yasuharu Tabara, et al.
American Journal of Hypertension|April 11, 2025
A Randomized Clinical Trial of ICT-based Interventions for Sodium and Potassium Regulation in Healthy AdultsYuichiro Yano, Kaori Kitaoka, Takayoshi Ohkubo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 3, 2024
Effects of renal denervation on blood pressure in patients with hypertension: a latest systematic review and meta-analysis of randomized sham-controlled trialsYukako Ogoyama, Makiko Abe, Keisuke Okamura, et al.
Cardiovascular Diabetology|June 17, 2020
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapyMasato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Pageof 72